Ladle, Brian H.
Johns Hopkins University · Sidney Kimmel Comprehensive Cancer Center
3 papers on CoChatORCID 0000-0002-5041-416X
Most cited papers
- Verified
De novo DNA methylation by DNA methyltransferase 3a controls early effector CD8 + T-cell fate decisions following activation
Ladle, B. H., Li, K.-P., Phillips, M. J., Pucsek, A. B., Haile, A., Powell, J. D., Jaffee, E. M., Hildeman, D. A., & Gamper, C. J. (2016) · Proceedings of the National Academy of Sciences
T-cell and B-cell ImmunologyEpigenetics and DNA Methylation
Cited by 152
- Verified
Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes
Ligon, J. A., Choi, W., Cojocaru, G., Fu, W., Hsiue, E. H.-C., Oke, T. F., Siegel, N., Fong, M. H., Ladle, B., Pratilas, C. A., et al. (2021) · Journal for ImmunoTherapy of Cancer
Cancer Immunotherapy and BiomarkersSarcoma Diagnosis and Treatment
Cited by 124
- Verified
Phase I/II, open-label, multicenter study of durvalumab in combination with tremelimumab in pediatric patients with advanced solid tumors
Hargrave, D., Marshall, L. V., André, N., Krystal, J., Ladle, B. H., Robbins, K. A., Hois, S., Armstrong, J., & Donegan, S. (2026) · Frontiers in Oncology
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 1
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free